巴楚医学

参考文献

[1] Ninni S,Algalarrondo V,Brette F,et al.Left atrial cardiomyopathy:pathophysiological insights,assessment methods and clinical implications[J].Arch Cardiovasc Dis,2024,117(4):283-296.

[2] Barbier P,Solomon S B,Schiller N B,et al.Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function[J].Circulation,1999,100(4):427-436.

[3] Vitarelli A,Gheorghiade M.Transthoracic and transesophageal echocardiography in the hemodynamic assessment of patients with congestive heart failure[J].Am J Cardiol,2000,86(4):36-40.

[4] Druzback昣 L,Valocik G,Jakubov昣 M,et al.Clinical implications of enlargement of left atrium[J].Vnitr Lek,2012,58(2):118-122.

[5] Ou Q Y,Chen Y T,Yu S S,et al.Prevalence of left atrial enlargement and its risk factors in general Chinese population[J].BMC Cardiovasc Disord,2016,16(1):53.

[6] Mehra R,Benjamin E J,Shahar E,et al.Association of nocturnal arrhythmias with sleep-disordered breathing:the sleep heart health study[J].Am J Respir Crit Care Med,2006,173(8):910-916.

[7] Heitmann K A,L?chen M L,Stylidis M,et al.Associations between physical activity,left atrial size and incident atrial fibrillation:the Troms? Study 1994—2016[J].Open Heart,2022,9(1):e001823.

[8] Lau Y F,Yiu K H,Siu C W,et al.Hypertension and atrial fibrillation:epidemiology,pathophysiology and therapeutic implications[J].J Hum Hypertens,2012,26(10):563-569.

[9] Sasson Z,Rasooly Y,Gupta R,et al.Left atrial enlargement in healthy obese:prevalence and relation to left ventricular mass and diastolic function[J].Can J Cardiol,1996;12(3):257-263.

[10] Pierdomenico S D,Pierdomenico A M,Di Carlo S,et al.Left atrial enlargement and risk of ischemic stroke in elderly treated hypertensive patients[J].Am J Hypertens,2014,27(9):1179-1184.

[11] Yaghi S,Moon Y P,Mora-McLaughlin C,et al.Left atrial enlargement and stroke recurrence:the northern Manhattan stroke study[J].Stroke,2015,46(6):1488-1493.

[12] Neradilova C,Gregorovicova M,Kovanda J,et al.“Form follows function”:the developmental morphology of the cardiac atria[J].Physiol Res,2024,73(S3):S697-S714.

[13] Susan Standring.Gray's Anatomy:The Anatomical Basis of Clinical Practice.42th Edition[M].London:Elsevier Press,2020:1079-1080.

[14] Chevalier P,Tabib A,Meyronnet D,et al.Quantitative study of nerves of the human left atrium[J].Heart Rhythm,2005,2(5):518-522.

[15] Ho S Y,Sanchez-Quintana D.The importance of atrial structure and fibers[J].Clin Anat,2009,22(1):52-63.

[16] Barbero U,Ho S Y.Anatomy of the atria :a road map to the left atrial appendage[J].Herzschr Elektrophys,2017,28(4):347-354.

[17] Kokubo Y,Matsumoto C.Hypertension is a risk factor for several types of heart disease:review of prospective studies[J].Adv Exp Med Biol,2017:956:419-426.

[18] Armstrong A C,Gidding S S,Colangelo L A,et al.Association of early adult modifiable cardiovascular risk factors with left atrial size over a 20-year follow-up period:the CARDIA study[J].BMJ Open,2014,4(1):e004001.

[19] Pritchett A M,Jacobsen S J,Mahoney D W,et al.Left atrial volume as an index ofleft atrial size:a population-based study[J].J Am Coll Cardiol,2003,41(6):1036-1043.

[20] Armstrong A C,Liu K,Lewis C E,et al.Left atrial dimension and traditional cardiovascular risk factors predict 20-year clinical cardiovascular events in young healthy adults:the CARDIA study[J].Eur Heart J Cardiovasc Imag,2014,15(8):893-899.

[21] Gidding S S,Carnethon M R,Daniels S,et al.Low cardiovascular risk is associated with favorable left ventricular mass,left ventricular relative wall thickness,and left atrial size:the CARDIA study[J].J Am Soc Echocardiogr,2010,23(8):816-822.

[22] Gupta S,Matulevicius S A,Ayers C R,et al.Left atrial structure and function and clinical outcomes in the general population[J].Eur Heart J,2013,34(4):278-285.

[23] Venteclef N,Guglielmi V,Balse E,et al.Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines[J].Eur Heart J,2015,36(13):795-805.

[24] Kira S,Abe I,Ishii Y,et al.Role of angiopoietin-like protein 2 in atrial fibrosis induced by human epicardial adipose tissue:analysis using an organo-culture system[J].Heart Rhythm,2020,17(9):1591-1601.

[25] Sandeep B,Ding W H,Huang X,et al.Mechanism and prevention of atrial remodeling and their related genes in cardiovascular disorders[J].Curr Probl Cardiol,2023,48(1):101414.

[26] Cameli M,Lisi M,Righini F M,et al.Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse[J].Am J Cardiol,2013,111(4):595-601.

[27] Qirko S,Tase M,Lushnjari V,et al.Left atrial contractility function in hypertension[J].Arch Mal Coeur Vaiss,1996,89(8):1003-1007.

[28] Davis C A,Rembert J C,Greenfield J C Jr.Compliance of left atrium with and without left atrium appendage[J].Am J Physiol,1990,259(4 Pt2):H1006-H1008.

[29] Sithara T,Drosatos K.Metabolic complications in cardiac aging[J].Front Physiol,2021,12:669497.

[30] Lee H Y,Oh B H.Aging and arterial stiffness[J].Circ J,2010,74(11):2257-2262.

[31] Abel E D,Litwin S E,Sweeney G.Cardiac remodeling in obesity[J].Physiol Rev,2008,88(2):389-419.

[32] Munger T M,Dong Y X,Masaki M,et al.Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation[J].J Am Coll Cardiol,2012,60(9):851-860.

[33] Shigematsu Y,Norimatsu S,Ogimoto A,et al.The influence of insulin resistance and obesity on left atrial size in Japanese hypertensive patients[J].Hypertens Res,2009,32(6):500-504.

[34] Niemann B,Chen Y,Teschner M,et al.Obesity induces signs of premature cardiac aging in younger patients[J].J Am Coll Cardiol,2011,57(5):577-585.

[35] Sletten A C,Peterson L R,Schaffer J E.Manifestations and mechanisms of myocardial lipotoxicity in obesity[J].J Intern Med,2018,284(5):478-491.

[36] Decoin R,Butruille L,Defrancq T,et al.High liver fibrosis scores in metabolic dysfunction-associated fatty liver disease patients are associated with adverse atrial remodeling and atrial fibrillation recurrence following catheter ablation[J].Front Endocrinol,2022,13:957245.

[37] Cernea S,Onisor D,Roiban A L,et al.Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes[J].World J Cardiol,2024,16(10):580-594.

[38] Wang L Y,Di Tullio M R,Beecham A,et al.A comprehensive genetic study on left atrium size in Caribbean hispanics identifies potential candidate genes in 17p10[J].Circ Cardiovasc Genet,2010,3(4):386-392.

[39] Chen Y C,Wijekoon S,Matsumoto A,et al.Distinct functional and molecular profiles between physiological and pathological atrial enlargement offer potential new therapeutic opportunities for atrial fibrillation[J].Clin Sci (Lond),2024,138(15):941-962.

[40] Ezeani M,Prabhu S.PI3K(p110α) as a determinant and gene therapy for atrial enlargement in atrial fibrillation[J].Mol Cell Biochem,2023,478(3):471-490.

[41] Kojima T,Kawasaki M,Tanaka R,et al.Left atrial global and regional function in patients with paroxysmal atrial fibrillation has already been impaired before enlargement of left atrium:velocity vector imaging echocardiography study[J].Eur Heart J Cardiovasc Imag,2012,13(3):227-234.

[42] Yamashita T,Sekiguchi A,Suzuki S,et al.Enlargement of the left atrium is associated with increased infiltration of immune cells in patients with atrial fibrillation who had undergone surgery[J].J Arrhythmia,2015,31(2):78-82.

[43] Packer M.Characterization,pathogenesis,and clinical implications of inflammation-related atrial myopathy as an important cause of atrial fibrillation[J].J Am Heart Assoc,2020,9(7):e015343.

[44] Yasuda M,Yasuda D,Tomooka K,et al.Plasma concentration of human atrial natriuretic hormone in patients with connective tissue diseases[J].Clin Rheumatol,1993,12(2):231-235.

[45] Luzuriaga G D C J,Arteaga-Fernandez E,Hotta V T,et al.Clinical and echocardiographic particularities of hypertrophic cardiomyopathy in a brazilian population and its prognostic impact[J].Arq Bras Cardiol,2025,122(4):e20240640.

[46] Losi M A,Mancusi C,Midtb? H,et al.Impact of estimated left atrial volume on prognosis in patients with asymptomatic mild to moderate aortic valve stenosis[J].Int J Cardiol,2019,297:121-125.

[47] Hidaka T,Shiwa T,Fujii Y,et al.Impact of aldosterone-producing adenoma on cardiac structures in echocardiography[J].J Echocardiogr,2013,11(4):123-129.

[48] Hirota N,Suzuki S,Arita T,et al.Left atrial dimension and ischemic stroke in patients with and without atrial fibrillation[J].Heart Vessels,2021,36(12):1861-1869.

[49] Chinali M,de Simone G,Roman M J,et al.Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome[J].J Am Coll Cardiol,2008,52(11):932-938.

[50] R?nningen P S,Berge T,Solberg M G,et al.Impact of blood pressure in the early 40s on left atrial volumes in the mid-60s:data from the ACE 1950 study[J].J Am Heart Assoc,2022,11(11):e023738.

[51] Iskandar A,Mujtaba M T,Thompson P D.Left atrium size in elite athletes[J].JACC Cardiovasc Imag,2015,8(7):753-762.

[52] Diaz Babio G,Vera Janavel G,Constantin I,et al.Atrial size and sports.A great training for a greater left atrium:how much is too much [J].Int J Cardiovasc Imag,2021,37(3):981-988.

[53] Abhayaratna W P,Seward J B,Appleton C P,et al.Left atrial size:physiologic determinants and clinical applications[J].J Am Coll Cardiol.2006,47(12):2357-2363.

[54] Donal E,Lund L H,Oger E,et al.Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction[J].Eur Heart J Cardiovasc Imag,2017,18(6):629-635.

[55] Pritchett A M,Mahoney D W,Jacobsen S J,et al.Diastolic dysfunction and left atrial volume:a population-based study[J].J Am Coll Cardiol,2005,45(1):87-92.

[56] Badui E,Delgado C,Enciso R,et al.Silent giant left atrium:a case report[J].Angiology,1995,46(5):445-448.

[57] Vohra S,Pradhan A,Jaiswal V,et al.Silent giant left atrium:a case report[J].Clin Case Rep,2022,10(2):e05363.

[58] Funk M,Perez M,Santana O.Asymptomatic giant left atrium[J].Clin Cardiol,2010,33(6):E104-E105.

[59] Casaclang-Verzosa G,Malouf J F,Scott C G,et al.Does left atrial size predict mortality in asymptomatic patients with severe aortic stenosis?[J].Echocardiography,2010,27(2):105-109.

[60] Palmiero P,Maiello M,Zito A,et al.Hypertensive cardiomyopathy in asymptomatic patients:a neglected diagnosis[J].Curr Hypertens Rev,2015,10(4):239-245.

[61] Park Y,Kim S,Shin J,et al.Frequent premature ventricular complex is associated with left atrial enlargement in patients with normal left ventricular ejection fraction[J].Pacing Clin Electrophysiol,2014,37(11):1455-1461.

[62] Henein M Y,Lindqvist P.Diastolic function assessment by echocardiography:a practical manual for clinical use and future applications[J].Echocardiography,2020,37(11):1908-1918.

[63] Zhang Y Y,Xu F,Chu M,et al.Pulmonary arterial hypertension in critically ill elderly patients[J].Pak J Med Sci,2017,33(1):27-32.

[64] Platonov P G.P-wave morphology:underlying mechanisms and clinical implications[J].Noninvasive Electrocardiol,2012,17(3):161-169.

[65] Madias J E.Peripheral edema masks the diagnoses of P pulmonale,P mitrale,and biatrial abnormality:clinical implications for patients with heart failure[J].Congest Heart Fail,2006,12(1):20-24.

[66] Edhouse J.ABC of clinical electrocardiography:conditions affecting the left side of the heart[J].BMJ,2002,324(7348):1264-1267.

[67] Chen S Y,Toh H S,Chang W T,et al.A rare cause of left atrium compression[J].Int Heart J,2021,62(4):944-948.

[68] Batista A A P,Lazzarin T,Pereira F W L,et al.Serum vitamin D levels,disease activity score-28 for rheumatoid arthritis with C-reactive protein (DAS28-CRP),and cardiac remodeling determined by ventricular dimensions and left atrium diameter in patients with rheumatoid arthritis:a prospective observational study[J].Med Sci Monit,2022,29:e938989 .

[69] Cabral Formigosa L A,dos Santos L F,Dantas Neres Martins J,et al.Management of primary cardiac leiomyosarcoma[J].Ecancermedicalscience,2023,17:1562.

[70] Viles-Gonzalez J F,Pastori L,Fischer A,et al.Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence,predictors,and clinical implications[J].Chest,2013,143(4):1085-1090.

[71] Di L Z,Pichette M,Nadeau R,et al.Severe bradyarrhythmia linked to left atrial dysfunction in Fabry disease-A cross-sectional study[J].Clin Cardiol,2018,41(9):1207-1213.

[72] Bloom M W,Gorevic P D.Cardiac amyloidosis[J].Ann Intern Med,2023,176(3):ITC33-ITC48.

[73] Shinzato K,Takahashi Y,Yamaguchi T,et al.Atrial amyloidosis identified by biopsy in atrial fibrillation:prevalence and clinical presentation[J].Eur Heart J,2025:ehaf332.

[74] Hu J,Tang B,Wang J,et al.Familial atrial enlargement,conduction disorder and symmetric cardiac hypertrophy are early signs of PRKAG2 R302Q[J].Curr Med Sci,2020,40(3):486-492.

[75] Hancock E W,Deal B J,Mirvis D M,et al.AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram:part V:electrocardiogram changes associated with cardiac chamber hypertrophy:a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee,Council on Clinical Cardiology;the American College of Cardiology Foundation;and the Heart Rhythm Society:Endorsed by the International Society for Computerized Electrocardiology[J].J Am Coll Cardiol,2009,53(11):992-1002.

[76] Lang R M,Badano L P,Mor-Avi V,et al.Recommendations for cardiac chamber quantification by echocardiography in adults:an update from the American Society of Echocardiography and the European Association of Cardiovascular imaging[J].J Am Soc Echocardiogr,2015,28(1):1-39.e14.

[77] Harkness A,Ring L,Augustine D X,et al.Normal reference intervals for cardiac dimensions and function for use in echocardiographic practice:a guideline from the British Society of Echocardiography[J].Echo Res Pract,2020,7(1):G1-G18.

[78] Maceira A M,Cosín-Sales J,Roughton M,et al.Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance[J].J Cardiovasc Magn Reson,2010,12(1):65.

[79] Kawel-Boehm N,Hetzel S J,Ambale-Venkatesh B,et al.Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children:2020 update[J].J Cardiovasc Magn Reson,2020,22(1):87.

[80] Fuchs A,Mejdahl M R,Kühl J T,et al.Normal values of left ventricular mass and cardiac chamber volumes assessed by 320-detector computed tomography angiography in the Copenhagen general population study[J].Eur Heart J Cardiovasc Imaging,2016,17(9):1009-1017.

[81] Ikenouchi T,Inaba O,Takamiya T,et al.The impact of left atrium size on selection of the pulmonary vein isolation method for atrial fibrillation:cryoballoon or radiofrequency catheter ablation[J].Am Heart J,2021,231:82-92.

[82] Nonaka H,Asami M,Horiuchi Y,et al.Prognostic impact of increase in left atrial volume following left atrial appendage closure:insights from the OCEAN-LAAC registry[J].Int J Cardiol Heart Vasc,2024,53:101449.

[83] Van Gelder I C,Rienstra M,Bunting K V,et al.2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)[J].Eur Heart J,2024,45(36):3314-3414.

[84] 中华医学会心血管病学分会，中国生物医学工程学会心律分会.心房颤动诊断和治疗中国指南[J].中华心血管病杂志，2023,51(6):572-618.

[85] Gard E K,Beale A L,Telles F,et al.Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction[J].European J Heart Fail,2023,25(6):806-814.

[86] Ramu B,Thenappan T.Evolving concepts of pulmonary hypertension secondary to left heart disease[J].Curr Heart Fail Rep,2016,13(2):92-102.

[87] Morrone D,Arbucci R,Wierzbowska-Drabik K,et al.Feasibility and functional correlates of left atrial volume changes during stress echocardiography in chronic coronary syndromes[J].Int J Cardiovasc Imag,2021,37(3):953-964.

[88] Purga S L,Karas M G,Horn E M,et al.Contribution of the left atrial remodeling to the elevated pulmonary capillary wedge pressure in patients with WHO Group Ⅱ pulmonary hypertension[J].J Echocardiogr,2019,17(4):187-196.

[89] Mentz R J,Ward J H,Hernandez A F,et al.Angiotensin-neprilysin inhibition in patients with mildly reduced or preserved ejection fraction and worsening heart failure[J].J Am Coll Cardiol,2023,82(1):1-12.

[90] Arbelo E,Protonotarios A,Gimeno J R,et al.2023 ESC guidelines for the management of cardiomyopathies[J].Eur Heart J,2023,44(37):3503-3626.

[91] Dalen H,et al.Diastolic function and dysfunction in athletes[J].Eur Heart J Cardiovasc Imag,2024,25(11):1537-1545.

[92] Heitmann K A,Welde B,L?chen M L,et al.Longitudinal associations between cumulative physical activity and change in structure and function of the left side of the heart:the troms? study 2007-2016[J].Front Cardiovasc Med,2022,9:882077.

[93] Herrera C,Bruňa V,Comella A,et al.Left atrial enlargement in competitive athletes and atrial electrophysiology[J].Rev Esp Cardiol (Engl Ed),2022,75(5):421-428.

[94] D'Ascenzi F,Solari M,Anselmi F,et al.Atrial chamber remodelling in healthy pre-adolescent athletes engaged in endurance sports:a study with a longitudinal design.The CHILD study[J].Int J Cardiol,2016,223:325-330.

[95] Apostolakis E,Shuhaiber J H.The surgical management of giant left atrium[J].Eur J Cardiothorac Surg,2008,33(2):182-190.